000 | 01929 a2200529 4500 | ||
---|---|---|---|
005 | 20250515035023.0 | ||
264 | 0 | _c20060918 | |
008 | 200609s 0 0 eng d | ||
022 | _a0741-5214 | ||
024 | 7 |
_a10.1016/j.jvs.2006.04.032 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aReece, T Brett | |
245 | 0 | 0 |
_aFunctional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism. _h[electronic resource] |
260 |
_bJournal of vascular surgery _cAug 2006 |
||
300 |
_a392-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdenosine A2 Receptor Agonists |
650 | 0 | 4 | _aAdenosine A2 Receptor Antagonists |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xmetabolism |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 |
_aParaplegia _xmetabolism |
650 | 0 | 4 |
_aPurines _xpharmacology |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aReceptor, Adenosine A2A _xmetabolism |
650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
650 | 0 | 4 |
_aSpinal Cord Ischemia _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTriazines _xpharmacology |
650 | 0 | 4 |
_aTriazoles _xpharmacology |
700 | 1 | _aKron, Irving L | |
700 | 1 | _aOkonkwo, David O | |
700 | 1 | _aLaurent, Jeffrey J | |
700 | 1 | _aTache-Leon, Carlos | |
700 | 1 | _aMaxey, Thomas S | |
700 | 1 | _aEllman, Peter I | |
700 | 1 | _aLinden, Joel | |
700 | 1 | _aTribble, Curtis G | |
700 | 1 | _aKern, John A | |
773 | 0 |
_tJournal of vascular surgery _gvol. 44 _gno. 2 _gp. 392-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jvs.2006.04.032 _zAvailable from publisher's website |
999 |
_c16479097 _d16479097 |